Taysha Gene Therapies, Inc. (TSHA) Insider Trading

Name: Taysha Gene Therapies, Inc. (TSHA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jul 10, 2026): Sukumar Nagendran (President and Head of R&D): Sale of 200,000 shares, $1.25M.

Get alerted when insiders trade TSHA

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta